Alpha-Defensin vs BNP (B-type Natriuretic Peptide)

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Alpha-Defensin

Alpha-defensins are small cationic peptides that are key components of the innate immune system. They have broad-spectrum antimicrobial activity against bacteria, fungi, and some viruses.

Full details →

BNP (B-type Natriuretic Peptide)

BNP is a cardiac neurohormone released primarily by ventricles in response to volume/pressure overload. It's a major biomarker for heart failure and has therapeutic applications as nesiritide.

Full details →

Side-by-Side Comparison

Aspect	Alpha-Defensin	BNP (B-type Natriuretic Peptide)
Dose Range	100 mcg–500 mcg	25 mcg–100 mcg
Frequency	1x daily	1x daily
Cycle Length	2–4 weeks	1–4 weeks
Route	subcutaneous	subcutaneous
Mechanism	Insert into microbial membranes to form pores, leading to cell death. Also have immunomodulatory effects including chemotaxis of immune cells and cytokine modulation.	Similar to ANP - activates NPR-A receptors to produce vasodilation, natriuresis, and RAAS suppression. Released in response to ventricular wall stress.
Typical Dosage	Research compound - dosing varies by application. Typically studied in laboratory and early clinical research settings rather than for general use.	Nesiritide (recombinant BNP): 2mcg/kg IV bolus followed by 0.01mcg/kg/min continuous infusion for acute decompensated heart failure.
Administration	Various routes studied including topical, local injection, and systemic administration depending on application.	Intravenous administration only. Used in acute care settings for heart failure. BNP levels also used diagnostically.
Side Effects	Limited human use data. May cause local inflammation. Potential for immune activation effects.	Hypotension (common and dose-limiting), headache, nausea, and potential renal function worsening in some patients.
Best For	Recovery & Healing Immune Support	Recovery & Healing